McKesson Corporation (LON:0JZU)
London · Delayed Price · Currency is GBP · Price in USD 782.10
-1.00 (-0.13%)
At close: Oct 15, 2025
McKesson Market Cap
McKesson has a market cap or net worth of 73.53 billion as of October 16, 2025. Its market cap has increased by 53.72% in one year.
Market Cap
73.53B
Enterprise Value
79.98B
Revenue
275.61B
Ranking
n/a
PE Ratio
31.84
Stock Price
782.10
Market Cap Chart
Since November 10, 1994, McKesson's market cap has increased from 904.45M to 73.53B, an increase of 8,030.28%. That is a compound annual growth rate of 15.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 73.53B | 27.25% |
| Dec 31, 2024 | 57.79B | 19.48% |
| Dec 29, 2023 | 48.37B | 9.56% |
| Dec 30, 2022 | 44.14B | 57.50% |
| Dec 31, 2021 | 28.03B | 37.03% |
| Dec 31, 2020 | 20.45B | 8.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 197.31B |
| GSK plc | 65.48B |
| Haleon | 30.47B |
| Smith & Nephew | 11.22B |
| ConvaTec Group | 4.82B |
| Hikma Pharmaceuticals | 3.99B |
| HUTCHMED (China) | 1.99B |
| Genus | 1.77B |